Category: Latest News
-

Vital Farms delivers robust 2025 performance and unveils $100M share buyback
Vital Farms (NASDAQ:VITL) reported solid fourth-quarter and full-year 2025 results on February 26, 2026, driven by strong revenue growth, operational expansion, and continued investment in supply capacity, while also announcing a new share repurchase program. For fiscal 2025, net revenue increased 25.3% year over year to $759.4 million, while adjusted EBITDA rose to $114 million…
-

GigaCloud Technology delivers record Q4 and full-year 2025 performance
GigaCloud Technology (NASDAQ:GCT) reported record financial results for both the fourth quarter and full year of 2025 on February 26, highlighting strong earnings growth, expanding marketplace activity, and a solid cash position. Fourth-quarter revenue increased 22.7% year over year to $362.7 million, while diluted earnings per share rose 36.8% to $1.04. For the full year,…
-

Avalon GloboCare shares jump after joining AMD AI Developer Program
Avalon GloboCare Corp. (NASDAQ:ALBT) shares skyrocketed more than 138% in premarket trading Thursday after the company revealed it had been accepted into the Advanced Micro Devices AI Developer Program, a move aimed at accelerating its artificial intelligence development initiatives. Through the program, Avalon will gain access to AMD Developer Cloud credits, specialized development tools, technical…
-

Thryv posts strong SaaS growth in 2025 as company pivots toward AI platform
Thryv Holdings Inc (NASDAQ:THRY) reported strong expansion in its software-as-a-service business for 2025, highlighting continued progress in its transition toward a subscription-based, AI-focused operating model. The company generated SaaS revenue of $461.0 million for the full year, marking a 34.2% increase compared with 2024, according to its latest earnings release. In the fourth quarter alone,…
-

Wells Fargo lowers Procept BioRobotics target after weak Q4 performance
Wells Fargo reduced its price target on Procept BioRobotics Corp (NASDAQ:PRCT) to $34 from $51 while reiterating its Overweight rating, citing disappointing fourth-quarter results and softer guidance for 2026. The medical technology company reported fourth-quarter revenue of $76 million, representing 12% year-over-year growth but falling well short of the Street’s $94 million expectation. The shortfall…
-

Antelope Enterprise unveils $1 million Bitcoin investment initiative
Antelope Enterprise Holdings Limited (NASDAQ:AEHL) has introduced a new digital asset strategy dubbed the “Genius Plan,” beginning with an initial $1 million investment in Bitcoin. The company said the move reflects its view that recent price weakness in Bitcoin offers an attractive entry point for long-term positioning. The strategy will roll out in five stages,…
-

Papa John’s shares slip as revenue shortfall overshadows earnings beat
Papa John’s International, Inc. (NASDAQ:PZZA) shares moved lower in premarket trading Thursday after the pizza chain reported fourth-quarter revenue that fell short of Wall Street expectations, despite delivering stronger-than-forecast earnings. The company posted adjusted diluted earnings per share of $0.34, topping analyst estimates of $0.32. Total revenue, however, declined 6% year over year to $498.2…
-

TopBuild shares slide after earnings miss and cautious 2026 outlook
TopBuild Corp. (NYSE:BLD) shares dropped about 4% in premarket trading Thursday after the insulation and building products company reported fourth-quarter earnings that came in slightly below Wall Street expectations and issued softer-than-anticipated guidance for 2026. Adjusted earnings per share totaled $4.50 for the quarter, narrowly missing analyst forecasts of $4.54. Revenue reached $1.49 billion, matching…
-

Fortrea shares slip after revenue miss overshadows quarterly results
Fortrea Holdings Inc. (NASDAQ:FTRE) reported fourth-quarter earnings on Thursday that fell short of revenue expectations, sending shares modestly lower in premarket trading despite operational progress late in the year. The contract research organization generated fourth-quarter revenue of $660.5 million, missing the analyst consensus forecast of $855 million and declining 5.2% from $697.0 million recorded in…
-

Integra LifeSciences beats Q4 expectations but outlook trails forecasts
Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported fourth-quarter results on Thursday that came in ahead of Wall Street estimates, although weaker near-term guidance tempered investor optimism despite a modest after-hours share gain. The medical technology company posted adjusted earnings per share of $0.83, topping analyst expectations of $0.80. Revenue totaled $434.9 million, slightly above the consensus…